Announcements

4 April 2025
Current Oncology | Top 10 Most Cited Papers in 2024

1. “Insulin Resistance: The Increased Risk of Cancers”
by Leszek Szablewski
Curr. Oncol. 2024, 31(2), 998-1027; https://doi.org/10.3390/curroncol31020075
Available online: https://www.mdpi.com/1718-7729/31/2/75

2. “Temozolomide (TMZ) in the Treatment of Glioblastoma Multiforme—A Literature Review and Clinical Outcomes”
by Marcin Jezierzański, Natalia Nafalska, Małgorzata Stopyra, Tomasz Furgoł, Michał Miciak, Jacek Kabut, Iwona Gisterek-Grocholska
Curr. Oncol. 2024, 31(7), 3994-4002; https://doi.org/10.3390/curroncol31070296
Available online: https://www.mdpi.com/1718-7729/31/7/296

3. “The Complex Tumor Microenvironment in Ovarian Cancer: Therapeutic Challenges and Opportunities”
by Bianca Garlisi, Sylvia Lauks, Caroline Aitken, Leslie M. Ogilvie, Cielle Lockington, Duncan Petrik, Jan Soeren Eichhorn and Jim Petrik
Curr. Oncol. 2024, 31(7), 3826-3844; https://doi.org/10.3390/curroncol31070283
Available online: https://www.mdpi.com/1718-7729/31/7/283

4. “BCG and Alternative Therapies to BCG Therapy for Non-Muscle-Invasive Bladder Cancer”
by Sarah Lidagoster, Reuben Ben-David, Benjamin De Leon and John P. Sfakianos
Curr. Oncol. 2024, 31(2), 1063-1078; https://doi.org/10.3390/curroncol31020079
Available online: https://www.mdpi.com/1718-7729/31/2/79

5. “Prognostic Impact of Histologic Subtype and Divergent Differentiation in Patients with Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multicenter Retrospective Study”
by Akinori Minato, Nobuki Furubayashi, Yujiro Nagata, Toshihisa Tomoda, Hiroyuki Masaoka, Yoohyun Song, Yoshifumi Hori, Keijiro Kiyoshima, Takahito Negishi, Kentaro Kuroiwa et al.
Curr. Oncol. 2024, 31(2), 862-871; https://doi.org/10.3390/curroncol31020064
Available online: https://www.mdpi.com/1718-7729/31/2/64

6. “Plasma Cell-Free Tumor Methylome as a Biomarker in Solid Tumors: Biology and Applications”
by Danielle Benedict Sacdalan, Sami Ul Haq and Benjamin H. Lok
Curr. Oncol. 2024, 31(1), 482-500; https://doi.org/10.3390/curroncol31010033
Available online: https://www.mdpi.com/1718-7729/31/1/33

7. “KRAS: Biology, Inhibition, and Mechanisms of Inhibitor Resistance”
by Leonard J. Ash, Ottavia Busia-Bourdain, Daniel Okpattah, Avrosina Kamel, Ariel Liberchuk and Andrew L. Wolfe
Curr. Oncol. 2024, 31(4), 2024-2046; https://doi.org/10.3390/curroncol31040150
Available online: https://www.mdpi.com/1718-7729/31/4/150

8. “Diagnostic Accuracy of Contrast-Enhanced Ultrasound (CEUS) in the Detection of Muscle-Invasive Bladder Cancer: A Systematic Review and Diagnostic Meta-Analysis”
by Antonio Tufano, Davide Rosati, Martina Moriconi, Valerio Santarelli, Vittorio Canale, Stefano Salciccia, Alessandro Sciarra, Giorgio Franco, Vito Cantisani and Giovanni Battista Di Pierro
Curr. Oncol. 2024, 31(2), 818-827; https://doi.org/10.3390/curroncol31020060
Available online: https://www.mdpi.com/1718-7729/31/2/60

9. “Fertility Preservation in Cervical Cancer—Treatment Strategies and Indications”
by Lina Salman and Allan Covens
Curr. Oncol. 2024, 31(1), 296-306; https://doi.org/10.3390/curroncol31010019
Available online: https://www.mdpi.com/1718-7729/31/1/19

10. “Large Language Models in Oncology: Revolution or Cause for Concern?”
by Aydin Caglayan, Wojciech Slusarczyk, Rukhshana Dina Rabbani, Aruni Ghose, Vasileios Papadopoulos and Stergios Boussios
Curr. Oncol. 2024, 31(4), 1817-1830; https://doi.org/10.3390/curroncol31040137
Available online: https://www.mdpi.com/1718-7729/31/4/137

More News...
Back to TopTop